Quality of Life of Non-transplant Candidate Multiple Myeloma Patients Treated With Early Bortezomib

NCT01060202 · clinicaltrials.gov ↗

COMPLETED

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Multiple Myeloma

Interventions

DRUG: No intervention

Sponsor

Janssen Korea, Ltd., Korea